Vertice Pharma Revenue and Competitors

New Providence, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Vertice Pharma's estimated annual revenue is currently $10.3M per year.(i)
  • Vertice Pharma's estimated revenue per employee is $201,000

Employee Data

  • Vertice Pharma has 51 Employees.(i)
  • Vertice Pharma grew their employee count by -4% last year.

Vertice Pharma's People

NameTitleEmail/Phone
1
Associate Director Product DevelopmentReveal Email/Phone
2
Senior Manager Regulatory AffairsReveal Email/Phone
3
Senior ManagerReveal Email/Phone
4
Associate ScientistReveal Email/Phone
5
Group LeaderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Vertice Pharma?

Vertice Pharma is a specialty pharmaceuticals company focused on improving patients health. Vertice Pharma develops, manufactures, markets, and distributes high-quality and affordable pharmaceutical products through its operating companies. Vertice Pharma has global headquarters in the United Kingdom and United States headquarters in New Jersey.

keywords:N/A

N/A

Total Funding

51

Number of Employees

$10.3M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vertice Pharma News

2022-04-19 - Pyruvate kinase (PK) deficiency Market Size, Trends, Technological ...

Kezar Life Sciences, Momenta Pharmaceuticals, Inc, ... Teva Pharmaceutical Industries Ltd, Zydus Cadila, Vertice Pharma, Concord Biotech,...

2022-04-17 - US Sucralfate Market: Future Forecast Assessed On The Basis Of ...

Major players operating in the U.S. sucralfate market include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and...

2022-04-06 - Clayton Pharmaceuticals and VistaPharm (a Vertice company ...

Clayton Pharmaceuticals and VistaPharm (a Vertice company) Receive FDA Approval for Sucralfate Oral Suspension...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.1M568%N/A
#2
$30.9M9527%$31.8M
#3
$27M111N/AN/A
#4
$28.4M11310%N/A
#5
$32.4M1205%N/A